gene

VEGF

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about VEGF: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1644Connections

2Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

Page for VEGF (Vascular Endothelial Growth Factor)

View on Wiki →

No AI portrait yet

🧬 Gene Info

Gene Symbol	VEGF
Aliases	Vascular Endothelial Growth Factor
Function	VEGF serves multiple physiological functions
Primary Expression	hippocampus, motor cortex, cerebellum, cortex, striatum
Pathways	Akt, Amyloid, Apoptosis, Complement, Epigenetic
UniProt ID	[P15692](https://www.uniprot.org/uniprot/P15692)
NCBI Gene ID	7422
GeneCards	VEGF
Human Protein Atlas	VEGF
Associated Diseases	Aging, Als, Alzheimer, Alzheimer's disease
Known Drugs/Compounds	bevacizumab, levodopa, LEVODOPA, QUERCETIN, rapamycin, RAPAMYCIN
Interactions	AB, ACHE, AD, AGING, AHR, AKT
KG Connections	1554 knowledge graph edges
Databases	GeneCards HPA STRING

Wiki Pages (17)

Knowledge base pages for this entity

Canonical Page

Alzheimer's Disease VEGF/Angiogenic Signaling and Cerebral Blood Flow Therapy Companies

company · 2020 words

→

VEGF and Angiogenesis Dysregulation in CBS/PSP

mechanism · 1678 words

→

Pericyte PDGFR/VEGFR Modulator Therapy for Neurodegeneration

therapy · 1490 words

→

Pathway Diagram

flowchart TD
    BMAL1["BMAL1
Circadian Regulator"]
    HIF1A["HIF1A
Hypoxia-Inducible Factor"]
    VEGF["VEGF
Vascular Endothelial
Growth Factor"]
    Angiogenesis["Angiogenesis
Blood Vessel Formation"]
    bevacizumab["Bevacizumab
Anti-VEGF Therapy"]
    
    ALS["ALS
Amyotrophic Lateral
Sclerosis"]
    MS["Multiple Sclerosis
Demyelinating Disease"]
    Alzheimer["Alzheimer's Disease
Neurodegeneration"]
    Dementia["Dementia
Cognitive Decline"]
    TBI["Traumatic Brain Injury
Acute Injury"]
    
    Neuropathy["Neuropathy
Nerve Damage"]
    Inflammation["Inflammation
Immune Response"]
    Cancer["Cancer
Malignancy"]
    
    BMAL1 -->|"regulates"| VEGF
    HIF1A -->|"regulates"| VEGF
    VEGF -->|"promotes"| Angiogenesis
    bevacizumab -->|"inhibits"| VEGF
    
    VEGF -->|"activates"| ALS
    VEGF -->|"expressed in"| MS
    VEGF -->|"associated with"| Alzheimer
    VEGF -->|"associated with"| Dementia
    VEGF -->|"protective against"| TBI
    
    VEGF -->|"expressed in"| Neuropathy
    VEGF -->|"associated with"| Inflammation
    VEGF -->|"activates"| Cancer
    
    Angiogenesis -->|"supports"| TBI
    Inflammation -->|"contributes to"| ALS
    Inflammation -->|"contributes to"| MS
    
    style VEGF fill:#006494
    style BMAL1 fill:#4a1a6b
    style HIF1A fill:#4a1a6b
    style bevacizumab fill:#1b5e20
    style Angiogenesis fill:#1b5e20
    style TBI fill:#1b5e20
    style ALS fill:#ef5350
    style MS fill:#ef5350
    style Alzheimer fill:#ef5350
    style Dementia fill:#ef5350
    style Inflammation fill:#ef5350
    style Cancer fill:#ef5350
    style Neuropathy fill:#5d4400

Outgoing (760)

Target	Relation	Type	Str
Cancer	therapeutic_target	disease	1.00
Tumor	therapeutic_target	disease	1.00
CANCER	therapeutic_target	gene	1.00
Als	therapeutic_target	disease	1.00
Ischemia	activates	disease	1.00
Angiogenesis	activates	pathway	1.00
Als	activates	disease	0.95
neovascularization	activates	process	0.91
VASCULAR PERMEABILITY	regulates	biological_process	0.90
colorectal cancer	therapeutic_target	disease	0.90
Vascular Remodelling	involved_in	process	0.90
endothelial cells	expressed_in	cell_type	0.90
POEMS Syndrome	involved_in	disease	0.90
AKT	therapeutic_target	gene	0.90
Mtor	therapeutic_target	pathway	0.90
Angiogenesis	inhibits	entity	0.90
MTOR	therapeutic_target	gene	0.90
Angiogenesis	associated_with	process	0.85
Cognitive Function	involved_in	phenotype	0.85
Breast Cancer	biomarker_for	disease	0.85
Cancer	inhibits	disease	0.85
Inflammation	activates	disease	0.85
Als	inhibits	disease	0.85
Cancer	activates	disease	0.85
Glymphatic Transport	regulates	process	0.85
Tumor	inhibits	disease	0.85
Colorectal Cancer	therapeutic_target	disease	0.85
ERK	activates	protein	0.82
Methamphetamine Toxicity	involved_in	mechanism	0.82
unfolded protein response	participates_in	pathway	0.80
PI3K	activates	gene	0.80
endothelial cells	associated_with	cell_type	0.80
blood-brain barrier	participates_in	pathway	0.80
ALS	biomarker_for	disease	0.80
IPF	inhibits	disease	0.80
APOE4	reverses	protein	0.80
Tumor Progression	involved_in	process	0.80
oxidative stress response	participates_in	pathway	0.80
endothelial cells	regulates	cell_type	0.80
Crow-Fukase syndrome	biomarker_for	disease	0.80
TNF-Α	activates	gene	0.80
Drug Resistance	therapeutic_target	pathway	0.80
GENES	activates	gene	0.80
Wnt	therapeutic_target	pathway	0.80
Angiogenesis	regulates	entity	0.80
CANCER	activates	gene	0.80
Mapk	therapeutic_target	pathway	0.80
Mapk	activates	pathway	0.80
Angiogenesis	therapeutic_target	pathway	0.80
CANCER	inhibits	gene	0.80

Incoming (884)

Source	Relation	Type	Str
ALZHEIMER'S DISEASE	associated_with	disease	1.00
bevacizumab	binds_to	drug	0.95
Irisin	upregulates	protein	0.90
Hu-Loaded Exosomes	downregulates	compound	0.90
BMAL1	regulates	gene	0.90
HIF1A	upregulates	gene	0.90
PI3K	therapeutic_target	gene	0.90
Hypoxia Response Elements	regulates	mechanism	0.85
HIF-1	upregulates	protein	0.85
SRPK1	upregulates	protein	0.85
TEK	phosphorylates	protein	0.80
APOE4	regulates	protein	0.80
HIF1A	regulates	gene	0.80
Adrenergic Receptor Blocker	upregulates	drug	0.80
ENDOTHELIAL CELLS	regulates	cell_type	0.80
aerobic exercise	activates	process	0.80
STAT3	activates	gene	0.80
TNF	activates	gene	0.80
TNF	associated_with	gene	0.74
MMP2	activates	gene	0.70
HIF1A	targets	gene	0.70
NEURONS	protects_against	cell_type	0.70
ENDOTHELIAL	expresses	cell_type	0.70
ENDOTHELIAL	enhances	cell_type	0.70
PARP1	activates	gene	0.70
ASTROCYTE	protects_against	cell_type	0.70
MMP9	activates	gene	0.70
BACE1	regulates	gene	0.70
ASTROCYTE	expresses	cell_type	0.70
ULK1	activates	gene	0.70
ACHE	activates	gene	0.70
CAT	targets	gene	0.70
HIF1A	inhibits	gene	0.70
NLRP3	activates	gene	0.70
DBH	activates	gene	0.70
SOD1	activates	gene	0.70
ATG7	activates	gene	0.70
TNF	transports	gene	0.70
RAGE	regulates	gene	0.70
BDNF	activates	gene	0.70
PDGF	activates	gene	0.70
ATG5	activates	gene	0.70
TAU	biomarker_for	gene	0.70
GASDERMIN	activates	gene	0.70
NFKB	activates	gene	0.70
STING	disrupts	gene	0.70
BECN1	activates	gene	0.70
SQSTM1	activates	gene	0.70
TFEB	activates	gene	0.70
ENDOTHELIAL	associated_with	cell_type	0.70

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Cerebral VSMC foam cells induce pericyte detachment via PDGF	0.473	neurodegeneration	How does P2RY12-mediated VSMC dysfunctio
Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α	0.470	neurodegeneration	What are the optimal oxygen pressure, du

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning VEGF in their description or question text

No additional research found

VEGF

Understanding Entity Pages

Summary

Wiki Pages (17)

VEGF (Vascular Endothelial Growth Factor)

VEGF/Angiogenesis Pathway in Neurodegeneration

VEGF Signaling and Cerebral Angiogenesis in Neurodegeneration

Alzheimer's Disease VEGF/Angiogenic Signaling and Cerebral Blood Flow Therapy Companies

VEGF and Angiogenesis Dysregulation in CBS/PSP

Pericyte PDGFR/VEGFR Modulator Therapy for Neurodegeneration

VEGF Angiogenesis Therapy for Parkinson's Disease

VEGFR1 (FLT1) Protein

Parkinson's Disease VEGF/Angiogenic Signaling Therapy Companies

Vascular Endothelial Growth Factor (VEGF)

VEGF and Angiogenesis Therapy

VEGFA — Vascular Endothelial Growth Factor A

VEGFB Protein

VEGFA Protein - Vascular Endothelial Growth Factor A

FLT1 Protein (VEGF Receptor 1)

VEGFR2 (KDR) Protein

VEGFB Gene